Plasma Proteomics-Based Biomarker Panel Can Predict ALS
By Elana Gotkine HealthDay Reporter
TUESDAY, Sept. 9, 2025 -- A plasma proteomics-based biomarker panel can predict amyotrophic lateral sclerosis (ALS) before emergence of symptoms, according to a study published online Aug. 19 in Nature Medicine.
Ruth Chia, Ph.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues conducted a cross-sectional study using the Olink Explore 3072 platform to examine plasma proteomics as a biomarker tool for ALS.
The researchers found that 33 proteins were differentially abundant in the plasma of 183 patients with ALS versus 309 controls. The findings were replicated in an independent cohort of 48 patients with ALS and 75 controls. Machine learning was applied to create a model that diagnosed ALS with high accuracy (area under the curve, 98.3 percent). The age of clinical onset was estimated by analyzing plasma samples from individuals before emergence of ALS symptoms, indicating that the disease process occurs years before symptom onset.
"With a test that allows for earlier detection of ALS, we have opportunities to enroll people in observational studies, and by extension, offer promising disease-modifying -- and hopefully disease-stopping -- medications, before ALS becomes debilitating," coauthor Alexander Pantelyat, M.D., from Johns Hopkins University School of Medicine in Baltimore, said in a statement.
Several authors have a patent pending on the diagnostic testing for ALS based on the proteomic panel. Two authors disclosed ties to Cerevel Therapeutics.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2025
Read this next
Alzheimer Disease Associated With Greater Neural Flexibility
TUESDAY, Sept. 9, 2025 -- Alzheimer disease (AD) is associated with greater neural flexibility (NF) in older adults, according to a study published online July 17 in...
AI Performs Well for Endoscopic Assessment of Crohn Disease
TUESDAY, Sept. 9, 2025 -- Artificial intelligence shows good performance for automating ulceration and mucosal injury quantitation with Crohn disease, according to a study...
Online Stock Photos of BP Measurement Rarely Align With Guidelines
TUESDAY, Sept. 9, 2025 -- Few online stock photo images of blood pressure (BP) measurement align with clinical guidelines, according to a study published online Sept. 8 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.